335 related articles for article (PubMed ID: 11595834)
21. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.
Costanzo A; Merlo P; Pediconi N; Fulco M; Sartorelli V; Cole PA; Fontemaggi G; Fanciulli M; Schiltz L; Blandino G; Balsano C; Levrero M
Mol Cell; 2002 Jan; 9(1):175-86. PubMed ID: 11804596
[TBL] [Abstract][Full Text] [Related]
22. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
Kaghad M; Bonnet H; Yang A; Creancier L; Biscan JC; Valent A; Minty A; Chalon P; Lelias JM; Dumont X; Ferrara P; McKeon F; Caput D
Cell; 1997 Aug; 90(4):809-19. PubMed ID: 9288759
[TBL] [Abstract][Full Text] [Related]
23. From p63 to p53 across p73.
Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
[TBL] [Abstract][Full Text] [Related]
24. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
25. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
26. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
27. Expression of the vascular endothelial growth factor gene is inhibited by p73.
Salimath B; Marmé D; Finkenzeller G
Oncogene; 2000 Jul; 19(31):3470-6. PubMed ID: 10918605
[TBL] [Abstract][Full Text] [Related]
28. The p53 family: same response, different signals?
Chen X
Mol Med Today; 1999 Sep; 5(9):387-92. PubMed ID: 10462750
[TBL] [Abstract][Full Text] [Related]
29. p73: in silico evidence for a putative third promoter region.
Sayan AE; Rossi M; Melino G; Knight RA
Biochem Biophys Res Commun; 2004 Jan; 313(3):765-70. PubMed ID: 14697257
[TBL] [Abstract][Full Text] [Related]
30. p73 induces apoptosis by different mechanisms.
Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E
Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.
Lehman JA; Waning DL; Batuello CN; Cipriano R; Kadakia MP; Mayo LD
J Biol Chem; 2011 Oct; 286(42):36631-40. PubMed ID: 21873427
[TBL] [Abstract][Full Text] [Related]
32. [The structure and cellular regulation of p73: their implication in anticancer therapy].
Zawacka-Pankau J; Maleńczyk K; Sznarkowska A
Postepy Hig Med Dosw (Online); 2010 Feb; 64():78-86. PubMed ID: 20231765
[TBL] [Abstract][Full Text] [Related]
33. [P73: a kin to the p52 tumor suppressor gene].
Caput D
Bull Cancer; 1997 Nov; 84(11):1081-2. PubMed ID: 9536991
[TBL] [Abstract][Full Text] [Related]
34. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
35. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?
Zawacka-Pankau J; Kostecka A; Sznarkowska A; Hedström E; Kawiak A
Cell Cycle; 2010 Feb; 9(4):720-8. PubMed ID: 20160513
[TBL] [Abstract][Full Text] [Related]
36. P53 family: at the crossroads in cancer therapy.
Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
38. The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting.
Lunghi P; Costanzo A; Mazzera L; Rizzoli V; Levrero M; Bonati A
Clin Cancer Res; 2009 Nov; 15(21):6495-502. PubMed ID: 19861456
[TBL] [Abstract][Full Text] [Related]
39. Absence of mutation of the p73 gene in astrocytic neoplasms.
Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
[TBL] [Abstract][Full Text] [Related]
40. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
